<DOC>
	<DOCNO>NCT00674154</DOCNO>
	<brief_summary>The primary aim study ass whether 6-months vitamin D supplement decrease PTH compare placebo treatment primary hyperparathyroidism .</brief_summary>
	<brief_title>Effect Vitamin D Treatment Primary Hyperparathyroidism</brief_title>
	<detailed_description>The study investigate effect safety six month vitamin D supplementation surgery primary hyperparathyroidism . Effects assess change calcium homeostasis , bone metabolism , quality life , muscle strength function .</detailed_description>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Hyperparathyroidism , Primary</mesh_term>
	<mesh_term>Hypercalcemia</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>PCaion &gt; 1,30 mmol/l PPTH &gt; 5 pmol/l POH25vitamin D &lt; 80 nmol/l Pcreatinin &gt; 120 mumol/l usage Etalpha , Mimpara Cancer Sarcoidosis malabsorption pancreatitis alcohol abuse pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>Primary hyperparathyroidism</keyword>
	<keyword>hypercalcemia</keyword>
</DOC>